IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of IRIDEX (NASDAQ:IRIX) in a report released on Saturday. The brokerage issued a hold rating on the medical equipment provider’s stock.

IRIDEX Stock Down 8.7 %

IRIX opened at $1.26 on Friday. The business has a 50 day moving average price of $1.62 and a two-hundred day moving average price of $1.71. IRIDEX has a 52 week low of $1.24 and a 52 week high of $3.65. The company has a market cap of $20.96 million, a PE ratio of -1.88 and a beta of 0.84. The company has a quick ratio of 0.85, a current ratio of 1.54 and a debt-to-equity ratio of 0.55.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.